Mechanisms of CD95 (APO-1/Fas)-mediated apoptosis

Current Opinion in Immunology

Volumn 10, Issue 5, 1998, Pages 545-551

  Peter, Marcus E ^a   Krammer, Peter H ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE PROTEINASE; CYTOCHROME C; FAS ANTIGEN; INTERLEUKIN 2; PROTEIN BCL 2; TUMOR NECROSIS FACTOR RECEPTOR;

APOPTOSIS; CELL DEATH; EMBRYO DEATH; ENZYME ACTIVATION; MITOCHONDRION; NONHUMAN; OLIGOMERIZATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TRANSGENE;

EID: 0031754828     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(98)80222-7     Document Type: Article

References (98)

1. Peter ME, Heufelder A, Hengartner MO. Advances in apoptosis research. Proc Natl Acad Sci USA. 94:1997;12736-12737.
2. Itoh N, Nagata S. A novel protein domain required for apoptosis. Mutational analysis of human Fas antigen. J Biol Chem. 268:1993;10932-10937.
3. Peter ME, Scaffidi C, Medema JP, Kischkel F, Krammer PH. The death receptors. Kumar S. Apoptosis, Problems and Diseases. 1998;25-63 Springer, Heidelberg.
4. Rehemtulla A, Hamilton CA, Chinnaiyan AM, Dixit VM. Ultraviolet radiation-induced apoptosis is mediated by activation of CD-95 (Fas/APO-1). J Biol Chem. 272:1997;25783-25786.
5. Aragane Y, Kulms D, Metze D, Wilkes G, Poppelmann B, Luger TA, Schwarz T. Ultraviolet light induces apoptosis via direct activation of CD95(Fas/APO-1) independently of its ligand CD95L. J Cell Biol. 140:1998;171-182.
6. Cuvillier O, Rosenthal DS, Smulson ME, Spiegel S. Sphingosine 1-phosphate inhibits activation of caspases that cleave poly(ADP-ribose) polymerase and lamins during Fas- and ceramide-mediated apoptosis in Jurkat T lymphocytes. J Biol Chem. 273:1998;2910-2916.
7. De Maria R, Lenti L, Malisan F, d'Agostino F, Tomassini B, Zeuner A, Rippo MR, Testi R. Requirement for GD3 ganglioside in CD95- and ceramide-induced apoptosis. Science. 277:1997;1652-1655.
8. De Maria R, Rippo MR, Schuchman EH, Testi R. Acidic sphingomyelinase (ASM) is necessary for fas-induced GD3 ganglioside accumulation and efficient apoptosis of lymphoid cells. J Exp Med. 187:1998;897-902.
9. Herr I, Wilhelm D, Bohler T, Angel P, Debatin KM. Activation of CD95 (APO-1/Fas) signaling by ceramide mediates cancer therapy-induced apoptosis. EMBO J. 16:1997;6200-6208.
10. Tepper AD, Boesen de Cock JG, de Vries E, Borst J, van Blitterswijk WJ. CD95/Fas-induced ceramide formation proceeds with slow kinetics and is not blocked by caspase-3/CPP32 inhibition. J Biol Chem. 272:1998;24308-24312.
11. Watts JD, Gu M, Polverino AJ, Patterson SD, Aebersold R. Fas-induced apoptosis of T cells occurs independently of ceramide generation. Proc Natl Acad Sci USA. 94:1997;7292-7296.
12. Gamen S, Anel A, Pieiro A, Naval J. Caspases are the main executioners of Fas-mediated apoptosis, irrespective of the ceramide signalling pathway. Cell Death Different. 5:1998;241-249.
13. Santana P, Pena LA, Haimovitz-Friedman A, Martin S, Green D, McLoughlin M, Cordon-Cardo C, Schuchman EH, Fuks Z, Kolesnick R. Acid sphingomyelinase-deficient human lymphoblasts and mice are defective in radiation-induced apoptosis. Cell. 86:1996;189-199.
14. Boesen-de Cock JG, Tepper AD, de Vries E, van Blitterswijk WJ, Borst J. CD95 (Fas/APO-1) induces ceramide formation and apoptosis in the absence of a functional acid sphingomyelinase. J Biol Chem. 273:1998;7560-7565.
15. Tomiuk S, Hofmann K, Nix M, Zumbansen M, Stoffel W. Cloned mammalian neutral sphingomyelinase: functions in sphingolipid signaling? Proc Natl Acad Sci USA. 95:1998;3638-3643.
16. Cosulich S, Clarke P. Apoptosis: does stress kill? Curr Biol. 6:1996;1586-1588.
17. Kischkel FC, Hellbardt S, Behrmann I, Germer M, Pawlita M, Krammer PH, Peter ME. Cytotoxicity-dependent APO-1(Fas/CD95)-associated Proteins Form a Death-inducing Signalling Complex (DISC) with the Receptor. EMBO J. 14:1995;5579-5588.
18. Boldin MP, Varfolomeev EE, Pancer Z, Mett IL, Camonis JH, Wallach D. A novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domain. J Biol Chem. 270:1995;7795-7798.
19. Chinnaiyan AM, O'Rourke K, Tewari M, Dixit VM. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell. 81:1995;505-512.
20. Muzio M, Chinnaiyan AM, Kischkel FC, O'Rourke K, Shevchenko A, Scaffidi C, Zhang M, Ni J, Gentz R, Mann M, et al. FLICE, a novel FADD-homologous ICE/CED-3-like protease, Is recruited to the CD95 (Fas/APO-1) Death-Inducing Signaling Complex (DISC). Cell. 85:1996;817-827.
21. Scaffidi C, Medema JP, Krammer PH, Peter ME. Two FLICE Isoforms, Caspase 8/a and Caspase 8/b, are recruited and activated by the CD95 Death-inducing Signaling Complex (DISC). J Biol Chem. 272:1997;26953-26958.
22. Boldin MP, Goncharov TM, Goltsev YV, Wallach D. Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death. Cell. 85:1996;803-815.
23. Fernandes-Alnemri T, Armstrong RC, Krebs J, Srinivasula SM, Wang L, Bullrich F, Fritz LC, Trapani JA, Tomaselli KJ, Litwack G, Alnemri ES. In vitro activation of CPP32 and Mch3 by Mch4, a novel human apoptotic cysteine protease containing two FADD-like domains. Proc Natl Acad Sci USA. 93:1996;7464-7469.
24. Medema JP, Scaffidi C, Kischkel FC, Shevchenko A, Mann M, Krammer PH, Peter ME. FLICE is activated by association with the CD95 Death-inducing Signaling Complex (DISC). of special interest EMBO J. 16:1997;2794-2804 This provides a detailed biochemical analysis of the activation of caspase-8 in vivo.
25. Stanger BZ, Leder P, Lee TH, Kim E, Seed B. RIP: a novel protein containing a death domain that interacts with Fas/APO-1 (CD95) in yeast and causes cell death. Cell. 81:1995;513-523.
26. Kelliher MA, Grimm S, Ishida Y, Kuo F, Stanger BZ, Leder P. The death domain kinase RIP mediates the TNF-induced NF-kappaB signal. of special interest Immunity. 8:1998;297-303 This reports the characterization of RIP (receptor-interacting protein)-knockout mice demontrating that RIP is essential for activation of the transcription factor NF-κB activation that is mediated by the TNF receptor.
27. Sato T, Irie S, Kitada S, Reed JC. FAP-1: a protein tyrosine phosphatase that associates with Fas. Science. 268:1995;411-415.
28. Saras J, Engstrom U, Gonez LJ, Heldin CH. Characterization of the interactions between PDZ domains of the protein-tyrosine phosphatase PTPL1 and the carboxyl-terminal tail of Fas. J Biol Chem. 272:1997;20979-20981.
29. Cuppen E, Nagata S, Wieringa B, Hendriks W. No evidence for involvement of mouse protein-tyrosine phosphatase-BAS-like Fas-associated phosphatase-1 in Fas-mediated apoptosis. J Biol Chem. 272:1997;30215-30220.
30. Yang X, Khosravi-Far R, Chang HY, Baltimore D. Daxx, a novel Fas-binding protein that activates JNK and apoptosis. Cell. 89:1997;1067-1076.
31. Yeh WC, Pompa JL, McCurrach ME, Shu HB, Elia AJ, Shahinian A, Ng M, Wakeham A, Khoo W, Mitchell K, et al. FADD: essential for embryo development and signaling from some, but not all, inducers of apoptosis. of outstanding interest Science. 279:1998;1954-1958 This reports the characterization of FADD (Fas-associated death domain)-knockout mice and describes that FADD is essential for CD95-mediated apoptosis and is required for proper heart formation.
32. Zhang J, Cado D, Chen A, Kabra NH, Winoto A. Fas-mediated apoptosis and activation-induced T-cell proliferation are defective in mice lacking FADD/Mort1. of outstanding interest Nature. 392:1998;296-300 In addition to the findings in [31] the authors elegantly show the importance of FADD (Fas-associated death domain) for T cell proliferation.
33. Cahill MA, Peter ME, Kischkel FC, Chinnayian AM, Dixit VM, Krammer PH, Nordheim A. CD95 (APO-1/Fas) induces activation of SAP kinases downstream of ICE-like proteases. Oncogene. 13:1996;2087-2096.
34. Wajant H, Johannes FJ, Haas E, Siemienski K, Schwenzer R, Schubert G, Weiss T, Grell M, Scheurich P. Dominant-negative FADD inhibits TNFR60-, Fas/Apo1- and TRAIL-R/Apo2-mediated cell death but not gene induction. Curr Biol. 8:1998;113-116.
35. Newton K, Harris AW, Bath ML, Smith KGC, Strasser A. A dominant interfering mutant of FADD/MORT1 enhances deletion of autoreactive thymocytes and inhibits proliferation of mature T lymphocytes. of outstanding interest EMBO J. 17:1998;706-718 This describes findings using a transgenic system that were essentially consistent with the conclusions described in annotation [32].
36. of outstanding interest Zornig M, Hueber AO, Evan G. p53-dependent impairment of T-cell proliferation in FADD dominant-negative transgenic mice. of outstanding interest Curr Biol. 8:1998;467-470 See annotation to [35].
37. of special interest Walsh CM, Wen BG, Chinnaiyan AM, O'Rourke K, Dixit VM, Hedrick SM. A role for FADD in T cell activation and development. of outstanding interest Immunity. 8:1998;439-449 See annotation to [35].
38. Xiang J, Chao DT, Korsmeyer SJ. BAX-induced cell death may not require interleukin 1 beta-converting enzyme-like proteases. Proc Natl Acad Sci USA. 93:1996;14559-14563.
39. McCarthy NJ, Whyte MK, Gilbert CS, Evan GI. Inhibition of Ced-3/ICE-related proteases does not prevent cell death induced by oncogenes, DNA damage, or the Bcl-2 homologue Bak. J Cell Biol. 136:1997;215-227.
40. Alnemri ES, Livingston DJ, Nicholson DW, Salvesen G, Thornberry NA, Wong WW, Yuan J. Human ICE/CED-3 protease nomenclature. Cell. 87:1996;171.
41. Thornberry NA, Rano TA, Peterson EP, Rasper DM, Timkey T, Garcia Calvo M, Houtzager VM, Nordstrom PA, Roy S, Vaillancourt JP, et al. A combinatorial approach defines specificities of members of the caspase family and granzyme B. Functional relationships established for key mediators of apoptosis. of outstanding interest J Biol Chem. 272:1997;17907-17911 This is a very comprehensive in vitro analysis of caspase specifities using a peptide library.
42. Muzio M, Stockwell BR, Stennicke HR, Salvesen GS, Dixit VM. An induced proximity model for caspase-8 activation. of special interest J Biol Chem. 273:1998;2926-2930 This work demonstrates that activation of caspase-8 does not depend on the activity of any other caspase and that caspase-8 activation can fully acount for all apoptotic features found during CD95-mediated apoptosis.
43. Martin DA, Siegel RM, Zheng L, Lenardo MJ. Membrane oligomerization and cleavage activates the caspase-8 (FLICE/MACHalpha1) death signal. of special interest J Biol Chem. 273:1998;4345-4349 See annotation to [42].
44. Yang X, Chang HY, Baltimore D. Autoproteolytic Activation of Pro Caspases by Oligomerization. of special interest Molec Cell. 1:1998;319-325 See annotation to [42].
45. Memon SA, Hou J, Moreno MB, Zacharchuk CM. Apoptosis induced by a chimeric Fas/FLICE receptor: lack of requirement for Fas- or FADD-binding proteins. of special interest J Immunol. 160:1998;2046-2049 See annotation to [42].
46. Hirata H, Takahashi A, Kobayashi S, Yonehara S, Sawai H, Okazaki T, Yamamoto K, Sasada M. Caspases are activated in a branched protease cascade and control distinct downstream processes in Fas-induced apoptosis. J Exp Med. 187:1998;587-600.
47. Medema JP, Toes REM, Scaffidi C, Zheng TS, Flavell RA, Melief CJM, Peter ME, Offringa R, Krammer PH. Cleavage of FLICE by granzyme B during cytotoxic T lymphocyte-induced apoptosis. of special interest Eur J Immunol. 27:1997;3492-3498 This is the first in vivo demonstration that granzyme B activates the apoptosis pathway in CTL targets by using primarily caspase-8 cleavage as the entry point.
48. Fulda S, Friesen C, Los M, Scaffidi C, Mier W, Benedict M, Nuñez G, Krammer PH, Peter ME, Debatin KM. Betulinic acid triggers CD95 (APO-1/Fas)- and p53-independent apoptosis via activation of caspases in neuroectodermal tumors. of special interest Cancer Res. 57:1997;4956-4964 This is the first demonstration of an anticancer drug that induces apoptosis by direct activation of mitochondria without requirement of the CD95 death receptor/ligand system.
49. Boesen-de Cock JG, de Vries JR, Williams GT, Borst J. The anti-cancer drug etoposide can induce caspase-8 processing and apoptosis in the absence of CD95 receptor-ligand interaction. Apoptosis. 3:1998;17-25.
50. Martin SJ, Green DR. Protease activation during apoptosis: death by a thousand cuts? Cell. 82:1995;349-352.
51. Tan X, Wang YJ. The caspase-RB connection in cell death. of special interest Trends Cell Biol. 8:1998;116-120 This provides an excellent and comprehensive overview on various caspase substrates.
52. Widmann C, Gibson S, Johnson GL. Caspase-dependent cleavage of signaling proteins during apoptosis. A turn-off mechanism for anti-apoptotic signals. J Biol Chem. 273:1998;7141-7147.
53. Kothakota S, Azuma T, Reinhard C, Klippel A, Tang J, Chu K, McGarry TJ, Kirschner MW, Koths K, Kwiatkowski DJ, Williams LT. Caspase-3-generated fragment of gelsolin: effector of morphological change in apoptosis. Science. 278:1997;294-298.
54. Caul'n C, Salvesen GS, Oshima RG. Caspase cleavage of keratin 18 and reorganization of intermediate filaments during epithelial cell apoptosis. of special interest J Cell Biol. 138:1997;1379-1394 This provides a good summary on cleavage of various members of the intermediate filament protein family by caspases.
55. Rudel T, Bokoch GM. Membrane and morphological changes in apoptotic cells regulated by caspase-mediated activation of PAK2. of special interest Science. 276:1997;1571-1574 This demonstrates a correlation between activation of the signaling molecule PAK2 (p21-activated kinase 2) and the ability of apoptosing cells to form apoptotic bodies.
56. Lee N, MacDonald H, Reinhard C, Halenbeck R, Roulston A, Shi T, Williams LT. Activation of hPAK65 by caspase cleavage induces some of the morphological and biochemical changes of apoptosis. of special interest Proc Natl Acad Sci USA. 94:1997;13642-13647 See annotation to [55].
57. Graves JD, Gotoh Y, Draves KE, Ambrose D, Han DKM, Wright M, Chernoff J, Clark EA, Krebs EG. Caspase-mediated activation and induction of apoptosis by the mammalian Ste20-like kinase Mst1. EMBO J. 17:1998;2224-2234.
58. FAK and disassembly of focal adhesions in human endothelial cell apoptosis. J Exp Med. 187:1998;579-586.
59. Wen LP, Fahrni JA, Troie S, Guan JL, Orth K, Rosen GD. Cleavage of focal adhesion kinase by caspases during apoptosis. J Biol Chem. 272:1997;26056-26061.
60. Ubeda M, Habener JF. The large subunit of the DNA replication complex C (DSEB/RF-C140) cleaved and inactivated by caspase-3 (CPP32/YAMA) during Fas-induced apoptosis. J Biol Chem. 272:1997;19562-19568.
61. Rheaume E, Cohen LY, Uhlmann F, Lazure C, Alam A, Hurwitz J, Sekaly RP, Denis F. The large subunit of replication factor C is a substrate for caspase-3 in vitro and is cleaved by a caspase 3-like protease during Fas-mediated apoptosis. EMBO J. 16:1997;6346-6354.
62. Enari M, Sakahira H, Yokoyama H, Okawa K, Iwamatsu A, Nagata S. A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. of outstanding interest Nature. 391:1998;43-50 This is an elegant biochemical identification and characterization of an endonuclease involved in oligosomal DNA degradation during apoptosis.
63. of special interest Halenbeck R, MacDonald H, Roulston A, Chen TT, Conroy L, Williams LT. CPAN, a human nuclease regulated by the caspase-sensitive inhibitor DFF-45. of outstanding interest Curr Biol. 8:1998;537-540 This reports the cloning of the human homolog of the endonuclease, caspase-activated DNase (see annotation to [62]).
64. Sakahira H, Enari M, Nagata S. Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis. of outstanding interest Nature. 391:1998;96-99 This reports the cloning and biochemical charterization of a protein, cleavage of which facilitates translocation of an endonuclease - caspase-activated DNase - into the nucleus.
65. Inohara N, Koseki T, Chen S, Wu X, Nuñez G. CIDE, a novel family of cell death activators with homology to the 45 kDa subunit of the DNA fragmentation factor. EMBO J. 17:1998;2526-2533.
66. of special interest Liu X, Zou H, Slaughter C, Wang X. DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis. of outstanding interest Cell. 89:1997;175-184 This provides characterization of a protein DFF-45 (identical to the inhibitor of caspase-activated DNase; see annotation to [62]) required for activation of a DNA-cleaving activity.
67. Susin SA, Zamzami N, Castedo M, Daugas E, Wang HG, Geley S, Fassy F, Reed JC, Kroemer G. The central executioner of apoptosis: multiple connections between protease activation and mitochondria in Fas/APO-1/CD95- and ceramide-induced apoptosis. of special interest J Exp Med. 186:1997;25-37 This is a demonstration of the importance of mitochondria for CD95-mediated apoptosis.
68. Zou H, Henzel WJ, Liu X, Lutschg A, Wang X. Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. of outstanding interest Cell. 90:1997;405-413 This reports the identification and elegant characterization of the long-sought-after human homolog of the Caenorhabditis elegans death-promoting-protein CED-4.
69. Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES, Wang X. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. of special interest Cell. 91:1997;479-489 This is a characterization and functional analysis of caspase-9 - previously described as Apaf-3.
70. Bossy-Wetzel E, Newmeyer DD, Green DR. Mitochondrial cytochrome c release in apoptosis occurs upstream of DEVD-specific caspase activation and independently of mitochondrial transmembrane depolarization. EMBO J. 17:1998;37-49.
71. Jürgensmeier JM, Xie Z, Deveraux Q, Ellerby L, Bredesen D, Reed JC. Bax directly induces release of cytochrome c from isolated mitochondria. Proc Natl Acad Sci USA. 95:1998;4997-5002.
72. Van der Heiden MG, Chandel NS, Williamson EK, Schumacker PT, Thompson CB. Bcl-xL regulates the membrane potential and volume homeostasis of mitochondria. Cell. 91:1997;627-637.
73. Rosse T, Olivier R, Monney L, Rager M, Conus S, Fellay I, Jansen B, Borner C. Bcl-2 prolongs cell survival after Bax-induced release of cytochrome c. Nature. 391:1998;496-499.
74. Adachi S, Cross AR, Babior BM, Gottlieb RA. Bcl-2 and the outer mitochondrial membrane in the inactivation of cytochrome c during Fas-mediated apoptosis. J Biol Chem. 272:1997;21878-21882.
75. Shimizu S, Eguchi Y, Kamiike W, Funahashi Y, Mignon A, Lacronique V, Matsuda H, Tsujimoto Y. Bcl-2 prevents apoptotic mitochondrial dysfunction by regulating proton flux. Proc Natl Acad Sci USA. 95:1998;1455-1459.
76. Scaffidi C, Fulda S, Srinivasan A, Friesen C, Li F, Tomaselli KJ, Debatin KM, Krammer PH, Peter ME. Two CD95 (APO-1/Fas) signaling pathways. of outstanding interest EMBO J. 17:1998;1675-1687 This reports the identification of two apoptosis signaling types that differ in their dependence on apoptogenic activities of mitochondria, providing an explanation for the differential ability of Bcl-2 or Bcl-xL to inhibit CD95-mediated apoptosis.
77. Marzo I, Brenner C, Zamzami N, Susin SA, Beutner G, Brdiczka D, Remy R, Xie ZH, Reed JC, Kroemer G. The permeability transition pore complex: a target for apoptosis regulation by caspases and Bcl-2-related proteins. of special interest J Exp Med. 187:1998;1261-1271 This demonstrates the reconstitution of the permeability pore complex in liposomes.
78. Kamada S, Washida M, Hasegawa J, Kusano H, Funahashi Y, Tsujimoto Y. Involvement of caspase-4(-like) protease in Fas-mediated apoptotic pathway. Oncogene. 15:1997;285-290.
79. Kamada S, Funahashi Y, Tsujimoto Y. Caspase-4 and caspase-5, members of the ICE/CED-3 family of cysteine proteases, are CrmA-inhibitable proteases. Cell Death Different. 4:1997;473-478.
80. L acts downstream of caspase-8 activation by the CD95 death-inducing signaling complex. J Biol Chem. 273:1998;3388-3393.
81. L functions downstream of caspase-8 to inhibit Fas- and tumor necrosis factor receptor 1-induced apoptosis of MCF7 breast carcinoma cells. J Biol Chem. 273:1998;4523-4529.
82. O'Connor L, Strasser A, O'Reilly LA, Hausmann G, Adams JM, Cory S, Huang DC. Bim: a novel member of the Bcl-2 family that promotes apoptosis. EMBO J. 17:1998;384-395.
83. L, is a potent death agonist. J Biol Chem. 273:1998;7783-7786.
84. Inohara N, Ekhterae D, Garcia I, Carrio R, Merino J, Merry A, Chen S, Nuñez G. Mtd, a Novel Bcl-2 Family Member Activates Apoptosis in the Absence of Heterodimerization with Bcl-2 and Bcl-XL. J Biol Chem. 273:1998;8705-8710.
85. Zhivotovsky B, Orrenius S, Brustugun OT, Doskeland SO. Injected cytochrome c induces apoptosis. Nature. 391:1998;449-450.
86. Hu Y, Benedict MA, Wu D, Inohara N, Nuñuz G. Bcl-XL interacts with Apaf-1 and inhibits Apaf-1-dependent caspase-9 activation. Proc Natl Acad Sci USA. 95:1998;4386-4391.
87. L, and Apaf-1 form a ternary complex. J Biol Chem. 273:1998;5841-5845.
88. Suda T, Hashimoto H, Tanaka M, Ochi T, Nagata S. Membrane Fas ligand kills human peripheral blood T lymphocytes, and soluble Fas ligand blocks the killing. J Exp Med. 186:1997;2045-2050.
89. Tanaka M, Itai T, Adachi M, Nagata S. Downregulation of Fas ligand by shedding. Nat Med. 4:1998;31-36.
90. Strasser A, Harris AW, Huang DC, Krammer PH, Cory S. Bcl-2 and Fas/APO-1 regulate distinct pathways to lymphocyte apoptosis. EMBO J. 14:1995;6136-6147.
91. Schneider TJ, Grillot D, Foote LC, Nuñez GE, Rothstein TL. Bcl-x protects primary B cells against Fas-mediated apoptosis. J Immunol. 159:1997;4834-4839.
92. Lacronique V, Mignon A, Fabre M, Viollet B, Rouquet N, Molina T, Porteu A, Henrion A, Bouscary D, Varlet P, et al. Bcl-2 protects from lethal hepatic apoptosis induced by an anti-Fas antibody in mice. Nat Med. 2:1996;80-86.
93. Rodriguez I, Matsuura K, Khatib K, Reed JC, Nagata S, Vassalli P. A bcl-2 transgene expressed in hepatocytes protects mice from fulminant liver destruction but not from rapid death induced by anti-Fas antibody injection. J Exp Med. 83:1996;1031-1036.
94. L. Oncogene. 16:1998;1383-1390.
95. Holmstrom TH, Chow SC, Elo I, Coffey ET, Orrenius S, Sistonen L, Eriksson JE. Suppression of Fas/APO-1-mediated apoptosis by mitogen-activated kinase signaling. J Immunol. 160:1998;2626-2636.
96. Häusler P, Papoff G, Eramo A, Reif K, Cantrell DA, Ruberti G. Protection of CD95-mediated apoptosis by activation of phosphatidylinositide 3-kinase and protein kinase B. Eur J Immunol. 28:1998;57-69.
97. Thome M, Schneider P, Hofmann K, Fickenscher H, Meinl E, Neipel F, Mattmann C, Burns K, Bodmer JL, Schroter M, Scaffidi C, et al. Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors. of outstanding interest Nature. 386:1997;517-521 This provides a description of a new class of viral proteins, containing death-effector domains, that inhibit CD95-mediated apoptosis at the death-inducing signaling complex.
98. Tschopp J, Thome M, Hofmann K, Meinl E. The fight of viruses against apoptosis. of special interest Curr Opin Genet Dev. 8:1998;82-87 This is an excellent overview of apoptosis-modulating gene products found in certain classes of viruses.